(Q35036200)

5 August 2017

1 reference

title

Genetic and environmental risk factors for idiopathic inflammatory myopathies (English)

1 reference

idiopathic inflammatory myopathy

5 August 2017

main subject

1 reference

Ann M Reed

1

1 reference

5 August 2017

Steven R Ytterberg

series ordinal

2

1 reference

5 August 2017

publication date

1 November 2002

1 reference

Rheumatic Diseases Clinics of North America

5 August 2017

published in

1 reference

5 August 2017

volume

28

1 reference

5 August 2017

issue

4

1 reference

5 August 2017

page(s)

891-916

1 reference

The use of case-parent triads to study joint effects of genotype and exposure

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Allowing for missing parents in genetic studies of case-parent triads

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Familial autoimmunity in pedigrees of idiopathic inflammatory myopathy patients suggests common genetic risk factors for many autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Prednisone Use in Concurrent Autoimmune Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Juvenile dermatomyositis in first cousins

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

FAMILIAL OCCURRENCE OF DERMATOMYOSITIS. CASE REPORTS AND A FAMILY SURVEY

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Familial inclusion body myositis among Kurdish-Iranian Jews

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Recurrent orbital myositis: report of a familial incidence

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Familial inclusion body myositis: Evidence for autosomal dominant inheritance

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Clinical, serologic, and immunogenetic features of familial idiopathic inflammatory myopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Genetic risk and protective factors for idiopathic inflammatory myopathy in Koreans and American whites: a tale of two loci.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Increased frequency of HLA-B8 in juvenile dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Immunogenetic studies of juvenile dermatomyositis: HLA-DR antigen frequencies.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Molecular genetic studies of major histocompatibility complex genes in children with Juvenile dermatomyositis: Increased risk associated with HLA-DQA1∗0501

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Clinical, serologic, and immunogenetic features in polish patients with idiopathic inflammatory myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Update on the genetics of the idiopathic inflammatory myopathies.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

HLA associations with inclusion body myositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

HLA allele distribution distinguishes sporadic inclusion body myositis from hereditary inclusion body myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Mapping of a candidate region for susceptibility to inclusion body myositis in the human major histocompatibility complex

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Immunogenetic studies of juvenile dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Juvenile dermatomyositis: the association of the TNF alpha-308A allele and disease chronicity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Association of the HLA-DQA1*0501 allele in multiple racial groups with juvenile dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

C4 complement allotypes in juvenile dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Strong association of dermatomyositis-specific Mi-2 autoantibodies with a tryptophan at position 9 of the HLA-DR beta chain

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

The clinical and immunogenetic features of patients with autoantibodies to the nucleolar antigen PM-Scl

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Serum autoantibody to the nucleolar antigen PM-Scl. Clinical and immunogenetic associations

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Rheumatoid arthritis (RA)-associated HLA-DR alleles form less stable complexes with class II-associated invariant chain peptide than non-RA-associated HLA-DR alleles

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Chimeric cells of maternal origin in juvenile idiopathic inflammatory myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Chimerism in children with juvenile dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Analysis of HLA-DM polymorphism in juvenile dermatomyositis (JDM) patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Activation of complement and coagulation in juvenile dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Hereditary complement (C2) deficiency with dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Polymorphisms in the IL-1 receptor antagonist gene VNTR are possible risk factors for juvenile idiopathic inflammatory myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Apolipoprotein E epsilon 4 in inclusion body myositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Apolipoprotein E and apolipoprotein E messenger RNA in muscle of inclusion body myositis and myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Clonal restriction of T-cell receptor expression by infiltrating lymphocytes in inclusion body myositis persists over time. Studies in repeated muscle biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

T-cell heterogeneity in muscle lesions of inclusion body myositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

T cell receptor beta-chain repertoire in inclusion body myositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

T cell receptor repertoire in polymyositis: clonal expansion of autoaggressive CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Association among somatic HPRT mutant frequency, peripheral blood T-lymphocyte clonality, and serologic parameters of disease activity in children with juvenile onset dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

β‐Amyloid precursor epitopes in muscle fibers of inclusion body myositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

The UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Physical and transcriptional map of the hereditary inclusion body myopathy locus on chromosome 9p12-p13

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Fine-structure mapping of the hereditary inclusion body myopathy locus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Clinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families: hereditary inclusion body myopathy, Paget disease of bone, and frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Prion codon 129 homozygosity and sporadic inclusion body myositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Methionine homozygosity at prion gene codon 129 may predispose to sporadic inclusion-body myositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

The epidemiology of polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

The incidence of juvenile dermatomyositis: results from a nation-wide study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Prevalence of Coxsackie B virus antibodies in patients with juvenile dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Evidence for seasonal variation in polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Childhood polymyositis: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Distinct seasonal patterns in the onset of adult idiopathic inflammatory myopathy in patients with anti-Jo-1 and anti-signal recognition particle autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Epidemic of acute inflammatory myopathy in Karnataka, south India: 30 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Benign acute childhood myositis: laboratory and clinical features

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

The relative prevalence of dermatomyositis and polymyositis in Europe exhibits a latitudinal gradient

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Drug-induced myopathies in man

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Drug-induced myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Noninfectious environmental agents associated with myopathies.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Penicillamine-induced polymyositis with complete heart block

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

D-penicillamine induced polymyositis causing complete heart block

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Fatal polymyositis in D-penicillamine-treated rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

D-penicillamine and polymyositis: the significance of the anti-Jo-1 antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

D-penicillamine-induced polymyositis in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Antibodies against double-stranded DNA and development of polymyositis during treatment with interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

The first case of polymyositis associated with interferon therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Dermatomyositis after interferon alpha treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Learning from the cerivastatin experience

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Myalgia and elevated creatine kinase activity associated with subcutaneous injections of diluent.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Myositis associated with growth hormone therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Familial occurrence of dermatomyositis and progressive scleroderma after injection of a local anaesthetic for dental treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Myositis associated with interleukin-2 therapy in a patient with metastatic renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Muco-cutaneous changes during long-term therapy with hydroxyurea in chronic myeloid leukaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Complex neuromuscular disorder in a patient with chronic myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

L-tryptophan-associated eosinophilic perimyositis, neuritis, and fasciitis. A clinicopathologic and laboratory study of 25 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

The Neuromuscular Pathology of the Eosinophilia-Myalgia Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Neuromuscular manifestations of L-tryptophan-associated eosinophilia-myalgia syndrome: a histomorphologic analysis of 14 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

L-tryptophan-associated eosinophilic fasciitis prior to the 1989 eosinophilia-myalgia syndrome outbreak

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Neuropathological studies on the toxic syndrome related to adulterated rapeseed oil in Spain

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Another case of polymyositis after ciguatera toxin exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Polymyositis after ciguatera toxin exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Dermatomyositis Associated With BCG Vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Dermatomyositis and vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Macrophagic myofasciitis: an emerging entity. Groupe d'Etudes et Recherche sur les Maladies Musculaires Acquises et Dysimmunitaires (GERMMAD) de l'Association Française contre les Myopathies (AFM).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Association between bovine collagen dermal implants and a dermatomyositis or a polymyositis-like syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Risk assessment of polymyositis/dermatomyositis after treatment with injectable bovine collagen implants

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Is there an association between injectable collagen and polymyositis/dermatomyositis?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Silica-associated connective tissue disease. A study of 24 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

A clinical and immunologic evaluation of women with silicone breast implants and symptoms of rheumatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Risk of connective tissue disease and related disorders among women with breast implants: a nation-wide retrospective cohort study in Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Myasthenia gravis and polymyositis as manifestations of chronic graft-versus-host-disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Polymyositis as a manifestation of chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Infectious agents associated with myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Myxovirus-Like Structures in a Case of Human Chronic Polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Inclusion body myositis: a chronic persistent mumps myositis?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Inclusion body myositis and paramyxoviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Inclusion body myositis: the mumps virus hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Inclusion body myositis: investigation of the mumps virus hypothesis by polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Viruses in idiopathic inflammatory myopathies: absence of candidate viral genomes in muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Coxsackie B neutralisation titres in polymyositis/dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Lack of detection of enteroviral RNA or bacterial DNA in magnetic resonance imaging-directed muscle biopsies from twenty children with active untreated juvenile dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Polymyositis accompanying Coxsackie virus B2 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Dermatomyositis, polymyositis, and Coxsackie-B-virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Detection of enterovirus specific RNA sequences in muscle biopsy specimens from patients with adult onset myositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Evidence for a novel picornavirus in human dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Search for persistent enterovirus infection of muscle in inflammatory myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Polymyositis and dermatomyositis: no persistence of enterovirus or encephalomyocarditis virus RNA in muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Absence of persistent infection with enteroviruses in muscles of patients with inflammatory myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Echovirus polymyositis in patients with hypogammaglobulinemia. Failure of high-dose intravenous gammaglobulin therapy and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Chronic enteroviral meningoencephalitis in agammaglobulinemic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Disseminated echovirus infection in a patient with multiple myeloma and a functional defect in complement. Treatment with intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Polymyositis associated with AIDS retrovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Neurological complications of acquired immune deficiency syndrome: Analysis of 50 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Immunocytochemical and virological characteristics of hiv-associated inflammatory myopathies: Similarities with seronegative polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

HTLV-1 and polymyositis in Jamaica

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

HTLV-1 associated polymyositis in Jamaica

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Clinical characteristics of HTLV-1 associated dermato-polymyositis. Seven cases from Martinique.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Failure to detect HTLV-I by in situ hybridization in the biopsied muscles of viral carriers with polymyositis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Human T lymphotropic virus type I and polymyositis and dermatomyositis in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Human immunodeficiency virus (HIV)-associated myopathy: immunocytochemical identification of an HIV antigen (gp 41) in muscle macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Search for HIV proviral DNA and amplified sequences in the muscle biopsies of patients with HIV polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Detection of HTLV‐I provirus by in situ polymerase chain reaction in mononuclear inflammatory cells in skeletal muscle of viral carriers with polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Polymyositis in patients infected with human T-cell leukemia virus type I: the role of the virus in the cause of the disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Identification of human T cell leukemia/lymphoma virus type I antibodies, DNA, and protein in patients with polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Isolation of the Encysted Form ofToxoplasma gondiifrom Human Skeletal Muscle and Brain

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Serologic evidence of toxoplasmosis among patients with polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Serologic evidence for acute toxoplasmosis in polymyositis-dermatomyositis. Increased frequency of specific anti-toxoplasma IgM antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Increased toxoplasma antibodies in idiopathic inflammatory muscle disease. A case-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Does Toxoplasma cause polymyositis? Report of a case of polymyositis associated with toxoplasmosis and a critical review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Acute toxoplasma myositis: an immunohistochemical and ultrastructural study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Lack ofToxoplasma gondii DNA in muscles of patients with inflammatory myopathy and increased anti-Toxoplasma antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Polymyositis in Chagas's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Dermatomyositis associated with Lyme disease: case report and review of Lyme myositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Borrelia burgdorferi myositis: report of eight patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Myositis in Lyme borreliosis: an immunohistochemical study of seven patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Lyme myositis: muscle invasion by Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Lyme disease in a 74‐year‐old forest owner with symptoms of dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Detection of Borrelia burgdorferi DNA in muscle of patients with chronic myalgia related to Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Juvenile dermatomyositis in a child infected with human parvovirus B19

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Dermatomyositis associated with the presence of parvovirus B19 DNA in muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

A causal role for parvovirus B19 infection in adult dermatomyositis and other autoimmune syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Human parvovirus B19 infection in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Musculoskeletal manifestations and autoantibody profile in 90 hepatitis C virus infected Israeli patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Inclusion body myositis associated with hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Polymyositis, pulmonary fibrosis, and hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Interstitial lung fibrosis and rheumatic disorders in patients with hepatitis C virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Hepatitis C infection and polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Hepatitis C virus infection and myositis: a polymerase chain reaction study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Detection of HCV-specific sequences in chronic myopathy with hepatitis C: improvement with interferon-alpha 2A therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Immune complex myositis associated with viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

Dermatomyositis and Whipple's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2802%2900029-7

7 January 2021

10.1016/S0889-857X(02)00029-7

Identifiers

DOI

1 reference

5 August 2017

1 reference